StonvexLoading…
StonvexStonvexStonvexCore line items from CNTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.00M | $0.00 | $6.85M | $0.00 |
Operating Income | $-207.69M | $-201.06M | $-171.28M | $-212.26M |
Net Income | $-197.53M | $-235.76M | $-151.09M | $-216.21M |
EPS (Diluted) | $-1.46 | $-2.06 | $-1.57 | $-2.31 |
Total Assets | $687.50M | $576.80M | $360.25M | $444.31M |
Total Liabilities | $160.63M | $175.25M | $124.00M | $108.14M |
Cash & Equivalents | $61.30M | $383.22M | $128.03M | $393.64M |
Free Cash Flow OCF − CapEx | $-194.19M | $-142.09M | $-160.51M | $-201.68M |
Shares Outstanding | 149.23M | 132.63M | 98.77M | 94.84M |